Denali Therapeutics
DNLI
#3487
Rank
A$6.10 B
Marketcap
A$38.44
Share price
1.44%
Change (1 day)
75.33%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: A$6.10 Billion

As of July 2026 Denali Therapeutics has a market cap of A$6.10 Billion. This makes Denali Therapeutics the world's 3487th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026A$6.10 B55.12%
2025A$3.93 B-17.53%
2024A$4.76 B9.55%
2023A$4.35 B-21.57%
2022A$5.55 B-26.12%
2021A$7.51 B-42.49%
2020A$13.06 B445.81%
2019A$2.39 B-13.79%
2018A$2.77 B57.51%
2017A$1.76 B

End of Day market cap according to different sources

On Jul 8th, 2026 the market cap of Denali Therapeutics was reported to be:

A$6.10 Billion
by Nasdaq info icon info icon
A$6.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Organovo
ONVO
A$5.28 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
A$0.54 B-91.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$2.21 B-63.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
A$2.89 B-52.51% Jersey